Overview

Intrathecal Hydromorphone for Labor Analgesia

Status:
Unknown status
Trial end date:
2019-12-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the effect of intrathecal hydromorphone on the duration of labor analgesia and the incidence of epidural-associated temperature increase in laboring parturients. We hypothesize that intrathecal administration of longer-acting hydromorphone will: 1. Prolong the duration and improve the quality of analgesia in labor, and 2. Decrease the incidence of epidural-associated temperature increase in labor.
Phase:
N/A
Details
Lead Sponsor:
Brigham and Women's Hospital
Treatments:
Bupivacaine
Fentanyl
Hydromorphone